GB9023023D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB9023023D0
GB9023023D0 GB909023023A GB9023023A GB9023023D0 GB 9023023 D0 GB9023023 D0 GB 9023023D0 GB 909023023 A GB909023023 A GB 909023023A GB 9023023 A GB9023023 A GB 9023023A GB 9023023 D0 GB9023023 D0 GB 9023023D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909023023A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BARLOW RICHARD B
VEALE MARK A
Original Assignee
BARLOW RICHARD B
VEALE MARK A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BARLOW RICHARD B, VEALE MARK A filed Critical BARLOW RICHARD B
Priority to GB909023023A priority Critical patent/GB9023023D0/en
Publication of GB9023023D0 publication Critical patent/GB9023023D0/en
Priority to AU87149/91A priority patent/AU8714991A/en
Priority to JP3516505A priority patent/JPH05504578A/en
Priority to PCT/GB1991/001810 priority patent/WO1992006958A1/en
Priority to EP91917741A priority patent/EP0506903A1/en
Priority to CA002072598A priority patent/CA2072598A1/en
Priority to GB9122083A priority patent/GB2249093A/en
Priority to ZA918381A priority patent/ZA918381B/en
Priority to PT99299A priority patent/PT99299A/en
Priority to FI922903A priority patent/FI922903A0/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
GB909023023A 1990-10-23 1990-10-23 Pharmaceutical compositions Pending GB9023023D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB909023023A GB9023023D0 (en) 1990-10-23 1990-10-23 Pharmaceutical compositions
GB9122083A GB2249093A (en) 1990-10-23 1991-10-17 Piperidine derivatives and their use in pharmaceutical compositions
EP91917741A EP0506903A1 (en) 1990-10-23 1991-10-17 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist
JP3516505A JPH05504578A (en) 1990-10-23 1991-10-17 pharmaceutical composition
PCT/GB1991/001810 WO1992006958A1 (en) 1990-10-23 1991-10-17 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist
AU87149/91A AU8714991A (en) 1990-10-23 1991-10-17 4-acetoxy-piperidine derivatives, process for their preparation and use as a muscarinic m3-receptor antagonist
CA002072598A CA2072598A1 (en) 1990-10-23 1991-10-17 Pharmaceutical compositions
ZA918381A ZA918381B (en) 1990-10-23 1991-10-21 Pharmaceutical compositions.
PT99299A PT99299A (en) 1990-10-23 1991-10-22 PREPARATION PROCESS OF N-SUBSTITUTED PIPERIDINE-4-OL ESTERS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
FI922903A FI922903A0 (en) 1990-10-23 1992-06-22 4-ACETOXIPIPERIDINE DERIVATIVES, DERAS FRAMSTAELLNINGSFOERFARANDE OCH ANVAENDNING SOM ANTAGONIST FOER MUSKARINA M-3 RECEPTORER.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909023023A GB9023023D0 (en) 1990-10-23 1990-10-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB9023023D0 true GB9023023D0 (en) 1990-12-05

Family

ID=10684199

Family Applications (2)

Application Number Title Priority Date Filing Date
GB909023023A Pending GB9023023D0 (en) 1990-10-23 1990-10-23 Pharmaceutical compositions
GB9122083A Withdrawn GB2249093A (en) 1990-10-23 1991-10-17 Piperidine derivatives and their use in pharmaceutical compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9122083A Withdrawn GB2249093A (en) 1990-10-23 1991-10-17 Piperidine derivatives and their use in pharmaceutical compositions

Country Status (9)

Country Link
EP (1) EP0506903A1 (en)
JP (1) JPH05504578A (en)
AU (1) AU8714991A (en)
CA (1) CA2072598A1 (en)
FI (1) FI922903A0 (en)
GB (2) GB9023023D0 (en)
PT (1) PT99299A (en)
WO (1) WO1992006958A1 (en)
ZA (1) ZA918381B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006635A1 (en) * 1993-09-02 1995-03-09 Yamanouchi Pharmaceutical Co., Ltd. Carbamate derivative and medicine containing the same
NO2005012I1 (en) 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin and pharmaceutically acceptable salts thereof
CA2179574A1 (en) * 1995-06-26 1996-12-27 Tomomi Okada Substituted piperidine derivative and medicine comprising the same
PE92198A1 (en) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd DERIVATIVES OF FLUORINE-CONTAINED 1,4-PIPERIDINE
PE20050231A1 (en) 2003-06-24 2005-05-20 Novartis Ag DERIVATIVES OF PIPERIDINIUM AND PYRROLIDINIUM AS ANTAGONISTS OF THE MUSCARINIC M3 RECEPTOR
GB0428418D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
WO2016100823A1 (en) * 2014-12-19 2016-06-23 The Broad Institute, Inc. Dopamine d2 receptor ligands
US10633336B2 (en) 2014-12-19 2020-04-28 The Broad Institute, Inc. Dopamine D2 receptor ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792043A (en) * 1971-11-30 1973-05-29 Ciba Geigy PIPERIDINE DERIVATIVES USED TO STABILIZE ORGANIC MATERIALS
IT1231238B (en) * 1987-09-21 1991-11-26 Angeli Inst Spa AMIDIDIC DERIVATIVES

Also Published As

Publication number Publication date
ZA918381B (en) 1993-04-21
CA2072598A1 (en) 1992-04-24
JPH05504578A (en) 1993-07-15
GB2249093A (en) 1992-04-29
AU8714991A (en) 1992-05-20
WO1992006958A1 (en) 1992-04-30
GB9122083D0 (en) 1991-11-27
PT99299A (en) 1992-08-31
FI922903A (en) 1992-06-22
EP0506903A1 (en) 1992-10-07
FI922903A0 (en) 1992-06-22

Similar Documents

Publication Publication Date Title
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
ZA915861B (en) Pharmaceutical compositions
GB9100465D0 (en) Pharmaceutical compositions
GB9011767D0 (en) Pharmaceutical compositions
GB9023023D0 (en) Pharmaceutical compositions
GB9115693D0 (en) Solid pharmaceutical compositions
GB9026080D0 (en) Pharmaceutical compositions
GB9003185D0 (en) Pharmaceutical compositions
ZA917596B (en) Pharmaceutical compositions
GB9015435D0 (en) Pharmaceutical compositions
GB9015418D0 (en) Pharmaceutical compositions
ZA915450B (en) Pharmaceutical composition
GB9021476D0 (en) Pharmaceutical compositions
GB9017202D0 (en) Pharmaceutical compositions
GB9027605D0 (en) Pharmaceutical compositions
GB9026882D0 (en) Pharmaceutical compositions
GB9016660D0 (en) Pharmaceutical compositions
GB9022025D0 (en) Pharmaceutical compositions
GB9026476D0 (en) Pharmaceutical compositions
GB9026391D0 (en) Pharmaceutical compositions
ZW10690A1 (en) Pharmaceutical compositions
GB9023655D0 (en) Pharmaceutical compositions
IL94075A0 (en) Pharmaceutical compositions
GB9014736D0 (en) Pharmaceutical compositions
GB9413572D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
730A Proceeding under section 30 patents act 1977